Kancera
KAN | FN
Overview
Corporate Details
- ISIN(s):
- SE0015658570 (+1 more)
- LEI:
- 5493002P3RCOFW6HI207
- Country:
- Sweden
- Address:
- Nanna Svartz väg 4, 171 65 SOLNA
- Website:
- https://kancera.com/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Develops small-molecule drugs for treating inflammation and cancer. Focused on advancing therapies to clinical trials.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Cyclezyme AB | Sweden | CYCLE | |
|
Cyxone AB | Sweden | CYXO | |
|
DBV Technologies | France | DBV | |
|
DEINOVE | France | ALDEI | |
|
Deutsche Biotech Innovativ AG | Germany | DBI | |
|
Devyser Diagnostics | Sweden | DVYSR | |
/other/Diamyd_Medical_AB_publ-logo.png?Expires=1749883626&Signature=O3dy9yO51on9zZNgg3F7eRfTxRhspBKu13ILsfTV9BmfV-br7dpq-Xgfj1gHhR7oC8xOeBvsq1YXz2TmoxQZbYjivoPmSgkll0czrZJJXxOk8KBP6A8JsPQybYrdUIUF8vipPvjkwR7QtNJSxxwuFWtPq~kFw0NTPyi-E3IcktDR-AYvb9tJh4bbh2DI3oFgeN1lJcut514pxjxXCzYASvuPgM6l4GLC2Mm2fFQyNCMyJl3RdMTw0~PujiAQoz-GL9Pjtva0-DoXZvYOT9QJtYhP2YMqIlGQdmj8QKGzL~B2jjhxLoWi8-nnX9nIQVoXXH0uRFpB97xjUiDixoqhaw__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
|
Diamyd Medical AB (publ) | Sweden | DMYD | |
|
Diasorin | Italy | DIA | |
| DNA Group (T.R.) Ltd. | Israel | DNA | ||
|
Double Bond Pharmaceutical International AB | Sweden | DBP B |